Previous 10 | Next 10 |
home / stock / prev:cc / prev:cc news
Vancouver, British Columbia--(Newsfile Corp. - May 30, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the " Company " or " PreveCeutical ") is providing an update with respect to the Management Cease Trade Order (" MCTO ") issued by the British Columbia Securiti...
Vancouver, British Columbia--(Newsfile Corp. - May 29, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the " Company " or " PreveCeutical ") is pleased to announce that further to its news release dated May 16, 2024, the Company has closed the first tranche of its non-...
Vancouver, British Columbia--(Newsfile Corp. - May 16, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the " Company " or " PreveCeutical ") is providing an update with respect to the Management Cease Trade Order (" MCTO ") issued by the British Columbia Securities Com...
A look at the top 10 most actives in Canada Tourmaline Oil Corp. (TOU) rose 0.8% to $65.84 on volume of 7,183,290 shares PreveCeutical Medical Inc. (PREV) fell 40.0% to $0.015 on volume of 2,441,020 shares Northern Uranium Corp. (UNO.H) rose 50.0% to $0.015 on volume of 2,171,015 shares ...
Vancouver, British Columbia--(Newsfile Corp. - May 2, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the " Company " or " PreveCeutical ") announces that the Company has missed the filing deadline of April 29, 2024 to file the Company's audited annual financ...
2023-12-04 10:00:34 ET %Obesity and diabetes have become a problem for developed world countries. To address the global rise of these issues, this company is pursuing a dual-gene therapy strategy using proprietary bionanotechnological approaches. The rational design of tissue-targeted b...
PREVECEUTICAL INITIATES PREPARATION OF PROOF-OF-CONCEPT PRECLINICAL STUDY FOR ITS DIABETES & OBESITY DUAL GENE THERAPY PROGRAM PREVECEUTICAL INITIATES PREPARATION OF PROOF-OF-CONCEPT PRECLINICAL STUDY FOR ITS DIABETES & OBESITY DUAL GENE THERAPY PROGRAM Canada NewsWire ...
PreveCeutical & Endosane Announces Innovative Preclinical Approaches to Assess Brain Availability of CBD And Pharmacologically Relevant Doses Following Intranasal CBD Application PreveCeutical & Endosane Announces Innovative Preclinical Approaches to Assess Brain Availability of...
PreveCeutical Showcases Dynamic Evolution in AI Strategy Canada NewsWire VANCOUVER, BC , Sept. 12, 2023 /CNW/ - PreveCeutical Medical Inc. (the "Company" or "PreveCeutical") (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H), PreveCeutical Medical Inc. marks today as an i...
PreveCeutical Engages New to the Street for Production & Broadcasting Services PreveCeutical Engages New to the Street for Production & Broadcasting Services Canada NewsWire VANCOUVER, BC , Aug. 31, 2023 /CNW/ - PreveCeutical Medical Inc. (the "Comp...
News, Short Squeeze, Breakout and More Instantly...
Preveceutical Medical Inc. Company Name:
PREV:CC Stock Symbol:
CNQC Market:
Preveceutical Medical Inc. Website:
Vancouver, British Columbia--(Newsfile Corp. - July 9, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the " Company " or " PreveCeutical ") is pleased to announce that, further to the Company's news release dated June 28, 2024, the Company has completed the filings of...
Mission Ready Solutions Inc. (MRS.H:CA) is expected to report for Q1 2024 Peruvian Metals Corp. (PER:CA) is expected to report for Q1 2024 Cielo Waste Solutions Corp. (CMC:CA) is expected to report for Q4 2024 Reliq Health Technologies Inc. (RHT:CA) is expected to report for Q3 2024 ...
Lomiko Metals Inc. (LMR:CA) is expected to report for Q3 2024 Organto Foods Inc. (OGO:CA) is expected to report for Q1 2024 PreveCeutical Medical Inc. (PREV:CNX) is expected to report for Q1 2024 Blue Horizon Global Capital Corp Com (BHCC:CNX) is expected to report for Q1 2024 Per...